Incidence and mortality of central nervous system tumors in France: Trends over the period 1978-2000 and influence of registration practices on results;Incidence et mortalité des tumeurs du système nerveux central en France: Évolution de 1978 à 2000 et influence des pratiques d'enregistrement sur les résultats

Revue d'Epidemiologie et de Sante Publique

Volumn 54, Issue 5, 2006, Pages 399-406

  Menegoz F ^a   Martin, E ^a   Danzon, A ^a   Mathieu Daude H ^a   Guizard, A V ^a   Mace Lesec'h J ^a   Raverdy, N ^a   Pasquier, B ^a   Colonna, M ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Registre du Cancer de l'Isere   (France)

Author keywords

Cancer; Central Nervous System; Incidence; Mortality; Registry; Trends

Indexed keywords

ARTICLE; BIOSTATISTICS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; POPULATION RESEARCH; PRACTICE GUIDELINE; SEX DIFFERENCE; SEX RATIO;

EID: 33751528176     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0398-7620(06)76738-4     Document Type: Article

References (14)

1. Remontet L, Estève J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51: 3-30.
2. Tyczynski J, Démaret E, Parkin DM. Standards and guidelines for cancer registration in Europe. Collection: Technical Publication, no 40. Lyon: IARC, 2003.
3. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II- Age-period-cohort models. Stat Med 1987; 6: 469-81.
4. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I- Age-period and age-cohort models. Stat Med 1987; 6: 449-67.
5. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Descriptive epidemiology. Vol. IV, Lyon: IARC, 1994.
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
7. Parkin DM, Whelan S, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Volume VII. Lyon: IARC Press, 1997.
8. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990; 336: 474-81.
9. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry-Amar M, Raverdy N, et al. Descriptive epidemiology of cerebral gliomas in France. Cancer 1997; 79: 1195-202.
10. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001; 7: 839-45.
11. Kyritsis AP, Yung WK, Leeds NE, Bruner J, Gleason MJ, Levin VA. Multifocal cerebral gliomas associated with secondary malignancies. Lancet 1992; 339: 1229-30.
12. Zarbo RJ, Baker PB, Howanitz PJ. The autopsy as a performance measurement tool. Diagnostic discrepancies and unresolved clinical questions: a College of American Pathologists Q-Probes study of 2.479 autopsies from 248 institutions. Arch Pathol Lab Med 1999; 123: 191-8.
13. Burton EC, Troxclair DA, Newman WP 3rd. Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect? JAMA 1998; 280: 1245-8.
14. Gurney JG, Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001; 13: 160-6.